51 related articles for article (PubMed ID: 24011553)
1. The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study.
Franceschini N; Voruganti VS; Haack K; Almasy L; Laston S; Goring HH; Umans JG; Lee ET; Best LG; Fabsitz RR; MacCluer JW; Howard BV; North KE; Cole SA
Hum Genet; 2010 Mar; 127(3):295-301. PubMed ID: 19921264
[TBL] [Abstract][Full Text] [Related]
2. Kidney-disease-associated variants of Apolipoprotein L1 show gain of function in cation channel activity.
Bruno J; Edwards JC
J Biol Chem; 2021; 296():100238. PubMed ID: 33380423
[TBL] [Abstract][Full Text] [Related]
3. Inaxaplin for the treatment of APOL1-associated kidney disease.
Gbadegesin R; Lane B
Nat Rev Nephrol; 2023 Aug; 19(8):479-480. PubMed ID: 37106136
[TBL] [Abstract][Full Text] [Related]
4. Keloids and associated comorbidities in underrepresented populations: a cross-sectional analysis of the All of Us database.
Pathak GN; Pathak SS; Truong TM; Sanabria B; Rao B
Arch Dermatol Res; 2023 Dec; 316(1):9. PubMed ID: 38038739
[No Abstract] [Full Text] [Related]
5. Cation Channel Activity of Apolipoprotein L1 is Modulated by Haplotype Background.
Winkler RL; Bruno J; Buchanan P; Edwards JC
J Am Soc Nephrol; 2022 Sep; 33(9):1673-1675. PubMed ID: 35840172
[No Abstract] [Full Text] [Related]
6. Effect of donor non-muscle myosin heavy chain (MYH9) gene polymorphisms on clinically relevant kidney allograft dysfunction.
Pazik J; Oldak M; Oziębło D; Materkowska DD; Sadowska A; Malejczyk J; Durlik M
BMC Nephrol; 2020 Sep; 21(1):380. PubMed ID: 32873246
[TBL] [Abstract][Full Text] [Related]
7. Association between
Zhao H; Ma L; Yan M; Wang Y; Zhao T; Zhang H; Liu P; Liu Y; Li P
J Diabetes Res; 2018; 2018():5068578. PubMed ID: 29862302
[TBL] [Abstract][Full Text] [Related]
8. Linking Race, Cancer Outcomes, and Tissue Repair.
Byun JS; Park S; Caban A; Jones A; Gardner K
Am J Pathol; 2018 Feb; 188(2):317-328. PubMed ID: 29137950
[TBL] [Abstract][Full Text] [Related]
9. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.
Freedman BI; Kopp JB; Langefeld CD; Genovese G; Friedman DJ; Nelson GW; Winkler CA; Bowden DW; Pollak MR
J Am Soc Nephrol; 2010 Sep; 21(9):1422-6. PubMed ID: 20688934
[TBL] [Abstract][Full Text] [Related]
10. APOL1 and nephropathy progression in populations of African ancestry.
Freedman BI
Semin Nephrol; 2013 Sep; 33(5):425-32. PubMed ID: 24119848
[TBL] [Abstract][Full Text] [Related]
11. Keloids and non-diabetic kidney disease: similarities and the APOL1-MYH9 haplotype as a possible genetic link.
Keeling BH; Taylor BR
Med Hypotheses; 2013 Nov; 81(5):908-10. PubMed ID: 24011553
[TBL] [Abstract][Full Text] [Related]
12. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians.
Tayo BO; Kramer H; Salako BL; Gottesman O; McKenzie CA; Ogunniyi A; Bottinger EP; Cooper RS
Int Urol Nephrol; 2013 Apr; 45(2):485-94. PubMed ID: 22956460
[TBL] [Abstract][Full Text] [Related]
14. MYH9 and APOL1 are both associated with sickle cell disease nephropathy.
Ashley-Koch AE; Okocha EC; Garrett ME; Soldano K; De Castro LM; Jonassaint JC; Orringer EP; Eckman JR; Telen MJ
Br J Haematol; 2011 Nov; 155(3):386-94. PubMed ID: 21910715
[TBL] [Abstract][Full Text] [Related]
15. MYH9 and APOL1 gene polymorphisms and the risk of CKD in patients with lupus nephritis from an admixture population.
Colares VS; Titan SM; Pereira Ada C; Malafronte P; Cardena MM; Santos S; Santos PC; Fridman C; Barros RT; Woronik V
PLoS One; 2014; 9(3):e87716. PubMed ID: 24658608
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
